{"id":108431,"date":"2021-05-26T04:54:20","date_gmt":"2021-05-26T04:54:20","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=108431"},"modified":"2022-05-18T05:30:11","modified_gmt":"2022-05-18T05:30:11","slug":"castleman-disease","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/","title":{"rendered":"Castleman disease"},"content":{"rendered":"<p>Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).<\/p>\n<hr \/>\n<p>An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-108431","post","type-post","status-publish","format-standard","hentry","category-c"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Castleman disease - Definition of Castleman disease<\/title>\n<meta name=\"description\" content=\"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Castleman disease - Definition of Castleman disease\" \/>\n<meta property=\"og:description\" content=\"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2021-05-26T04:54:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-05-18T05:30:11+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/\",\"name\":\"Castleman disease - Definition of Castleman disease\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2021-05-26T04:54:20+00:00\",\"dateModified\":\"2022-05-18T05:30:11+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Castleman disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Castleman disease - Definition of Castleman disease","description":"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/","og_locale":"en_US","og_type":"article","og_title":"Castleman disease - Definition of Castleman disease","og_description":"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/","og_site_name":"Glossary","article_published_time":"2021-05-26T04:54:20+00:00","article_modified_time":"2022-05-18T05:30:11+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/","name":"Castleman disease - Definition of Castleman disease","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2021-05-26T04:54:20+00:00","dateModified":"2022-05-18T05:30:11+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"Castleman disease (CD), also referred to as angiofollicular lymph node hyperplasia, is a heterogeneous group of lymphoproliferative disorders, characterized by abnormal growth of the lymph nodes. There are three histopathological variants of CD: hyaline-vascular type, which accounts for approximately 80-90% of reported cases; plasma cell type; and an intermediate, or mixed, histological type. Clinical presentation of CD appears to be either localized or generalized (multicentric); however, there is controversy about whether the multicentric form is a distinct entity or simply a form of the plasma cell type (National Organization for Rare Disorders, Inc. [NORD], 2000). There is also some evidence that CD constitutes a spectrum of benign to malignant diseases and that if left untreated, the benign form of the disease may serve as a precursor to the malignant form (Parez et al.).An occasionally aggressive illness marked by excessive growth of lymphoid tissue either localized in a single lymph node group or in multiple regions of the body. Although the cause is not precisely known, its associations with acquired immunodeficiency syndrome, Kaposi\u2019s sarcoma, and human herpes virus 8 infection have led some experts to propose that it has an infectious basis. Localized disease responds well to surgical resection. Widespread disease can sometimes be treated effectively with chemotherapy.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/castleman-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Castleman disease"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108431","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=108431"}],"version-history":[{"count":2,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108431\/revisions"}],"predecessor-version":[{"id":159737,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/108431\/revisions\/159737"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=108431"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=108431"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=108431"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}